| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer
1 company
Hansen Gwenn is a Chief Scientific Officer at Nurix Therapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $1.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,633 | $5.20 | $8,487.35 | -4.6% | +49.7% | +330.6% | |
| Jul 31, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,884 | $9.65 | $18,189.45 | -5.9% | -45.8% | +113.9% | |
| May 1, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,136 | $9.88 | $11,219.48 | -4.1% | -1.9% | +21.4% | |
| Jan 30, 2023 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,412 | $11.78 | $16,632.80 | -5.8% | -16.6% | -32.7% | |
| Oct 31, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,165 | $12.88 | $15,005.78 | -5.2% | -6.8% | -56.1% | |
| Aug 1, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,186 | $15.67 | $18,584.62 | -5.8% | -17.4% | -38.4% | |
| May 2, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,098 | $11.75 | $12,901.50 | -6.0% | +28.8% | -21.4% | |
| Jan 3, 2022 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 1,828 | $28.96 | $52,938.88 | -11.4% | -51.1% | -63.4% | |
| Dec 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $29.13 | $11,652.00 | -2.7% | -45.3% | -57.1% | |
| Nov 1, 2021 | NRIX Nurix Therapeutics, Inc. | Chief Scientific Officer | Sale+OE | 400 | $33.24 | $13,296.00 | -2.7% | -46.0% | -61.8% |